Industry sponsor intelligence

Helsinn Therapeutics (U.S.), IncClinical Pipeline.

Lead-sponsor view of Helsinn Therapeutics (U.S.), Inc's indexed peptide studies, development phases, active programs, completed work and recent registry changes.

Total: 2
Recruiting: 0
Active: 0
Completed: 2
Results posted: 0
Avg enrollment: 219

Pipeline overview

Programs by phase and activity.

Velocity

Helsinn Therapeutics (U.S.), Inc trials by start year

Study start year · indexed snapshot

Development

Trials by phase

2phase labels

Early Phase 10

Phase 10

Phase 22

Phase 30

Phase 40

Product	Studies	Early / I	Phase II	Phase III	Phase IV	Active
Ipamorelin →	2	0	2	0	0	0

Active peptide trials

In motion now.

No studies in this snapshot.

Completed trials

Finished registry records.

NCT IDStudyPhase / statusEnrollmentUpdated

NCT00672074

Safety and Efficacy of Ipamorelin for Management of Post-Operative Ileus

Helsinn Therapeutics (U.S.), Inc · Ileus

Phase 2

Completed

117

2017-04

NCT01280344

Safety and Efficacy of Ipamorelin Compared to Placebo for the Recovery of Gastrointestinal Function

Helsinn Therapeutics (U.S.), Inc · Gastrointestinal Dysmotility

Phase 2

Completed

320

2017-04

Search sponsor records

All Helsinn Therapeutics (U.S.), Inc studies.

This page groups studies where Helsinn Therapeutics (U.S.), Inc is listed as the lead industry sponsor. Collaborator-only records are not included in the count.